Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of the National Comprehensive Cancer Network : JNCCN|April 11, 2022
Response of Leptomeningeal Metastasis of Breast Cancer With a HER2/neu Activating Variant to Tucatinib: A Case ReportFengting Yan, Kristine J Rinn, Jonathon A Kullnat, et al.
Academic Radiology|August 21, 2002
Use of serial FDG PET to measure the response of bone-dominant breast cancer to therapyStephanie E Stafford, Julie R Gralow, Erin K Schubert, et al.
Nuclear Medicine and Biology|October 17, 2002
[Tc-99m]-sestamibi uptake and washout in locally advanced breast cancer are correlated with tumor blood flowDavid A Mankoff, Lisa K Dunnwald, Julie R Gralow, et al.
Breast Cancer Research and Treatment|December 20, 2013
A phase II study of docetaxel and vinorelbine plus filgrastim for HER-2 negative, stage IV breast cancer: SWOG S0102Julie R Gralow, William E Barlow, Danika Lew, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2009
A phase I trial of immunotherapy with lapuleucel-T (APC8024) in patients with refractory metastatic tumors that express HER-2/neuPrema P Peethambaram, Michelle E Melisko, Kristine J Rinn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2014
SWOG S0221: a phase III trial comparing chemotherapy schedules in high-risk early-stage breast cancerGeorge T Budd, William E Barlow, Halle C F Moore, et al.
Pageof 1